Meeting
2018 ASCO Annual Meeting
The comparison of tumor mutational burden (TMB) in patients of early and late stage lung adenocarcinoma in China.
Authors
Kai Zhang
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
Kai Zhang , Shihong Fei , Jing Lu , Qifan Yang , Jinsong Yang , Yulan Zeng , Yuting Liu , Xiaodong Jiao , Ye Tao , Zhen Yuan , Wei Gao , Zhao Wei , Di Liu , Tongfu Xu , Shangli Cai , Fu-Gen Li , Rubo Cao , Li Liu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 36, 2018 (suppl; abstr 8520)
DOI
10.1200/JCO.2018.36.15_suppl.8520
Abstract #
8520
Poster Bd #
126
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Association of CDKN2A gene alteration with high expression of PD-L1.
First Author: Yan Zhang
Poster
2022 ASCO Annual Meeting
Evaluation of stage IV pancreatic adenocarcinomas based on mutational profiling of tumors.
First Author: Katherine E Poruk
Poster
2022 ASCO Annual Meeting
Identifying biomarkers associated with disease-free survival in stage I non–small cell lung cancer.
First Author: Christopher W. Seder
Poster
2022 ASCO Annual Meeting
Mutational landscape of pancreatic adenocarcinoma identified by prospective clinical sequencing in a nationwide cancer network.
First Author: Katherine E Poruk